Literature DB >> 16123490

Back to basics in diagnosing diabetic polyneuropathy with the tuning fork!

Jan-Willem G Meijer1, Andries J Smit, Joop D Lefrandt, Johannes H van der Hoeven, Klaas Hoogenberg, Thera P Links.   

Abstract

OBJECTIVE: Several national and international scoring systems are used to diagnose diabetic polyneuropathy (PNP). The variety in these scores and the lack of data on validity and predictive value has led to a comparison and validation of the scores with clinical standards for PNP to determine the most powerful measurement for screening. RESEARCH DESIGN AND METHODS: Three matched groups were selected: 24 diabetic patients with neuropathic foot ulcers, 24 diabetic patients without PNP or ulcers, and 21 control subjects without diabetes. In all participants the scores from the International Consensus on the Diabetic Foot (ICDF) and the Dutch Nederlandse Diabetes Federatie-Centraal Beleids Orgaan (NDF/CBO) were tested. The Diabetic Neuropathy Symptom score, the Diabetic Neuropathy Examination score, Heart Rate Variability, the Nerve Conduction Sum score, and a San Antonio Consensus sum score were obtained as clinical standards. Reproducibility was tested in a separate study (13 patients).
RESULTS: The construct validity and discriminative power of the ICDF and NDF/CBO scores were comparable, although monofilaments (NDF/CBO) scored lower. The predictive value was good for all scores, with the best results being obtained for the tuning fork (NDF/CBO). Reproducibility of the NDF/CBO scores (monofilaments and tuning fork) was high.
CONCLUSIONS: The characteristics of the scores of tests recommended by ICDF and NDF/CBO are comparable. The single use of the 128-Hz tuning fork produces results similar to the extended scores of the ICDF and much better than those of monofilaments on validation and for predictive value. For screening we therefore advise the use of the tuning fork alone.

Entities:  

Mesh:

Year:  2005        PMID: 16123490     DOI: 10.2337/diacare.28.9.2201

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  25 in total

1.  The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy.

Authors:  C J Currie; C D Poole; A Woehl; C Ll Morgan; S Cawley; M D Rousculp; M T Covington; J R Peters
Journal:  Diabetologia       Date:  2006-08-30       Impact factor: 10.122

2.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

Review 3.  Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review.

Authors:  Jacquelien Dros; Astrid Wewerinke; Patrick J Bindels; Henk C van Weert
Journal:  Ann Fam Med       Date:  2009 Nov-Dec       Impact factor: 5.166

4.  Transcobalamin 776C→G polymorphism is associated with peripheral neuropathy in elderly individuals with high folate intake.

Authors:  Hathairat Sawaengsri; Peter R Bergethon; Wei Qiao Qiu; Tammy M Scott; Paul F Jacques; Jacob Selhub; Ligi Paul
Journal:  Am J Clin Nutr       Date:  2016-10-12       Impact factor: 7.045

5.  Choosing a Vibratory Test to Pair With Semmes Weinstein Monofilament Testing for Evaluating Lower Extremity Sensation in Patients With Diabetes: A Comparison of Three Vibratory Methodologies.

Authors:  Bryan Raymond; James Steriovski; KaNesha Gillyard; Chalen Yang; Stephanie C Wu; Ryan T Crews
Journal:  J Diabetes Sci Technol       Date:  2019-05-21

6.  [Resources and models for diabetic foot care in Catalonia (Spain): a descriptive study on areas of improvement].

Authors:  Jerónimo Jurado-Campos; Edurne Zabaleta-Del-Olmo; Carme Farré-Grau; Josep Barceló-Prats; Dolors Juvinyà-Canal
Journal:  Aten Primaria       Date:  2011-10-28       Impact factor: 1.137

7.  The effects of Vibro-medical insole on vibrotactile sensation in diabetic patients with mild-to-moderate peripheral neuropathy.

Authors:  Masumeh Bagherzadeh Cham; Mohammad Ali Mohseni-Bandpei; Mahmood Bahramizadeh; Saeed Kalbasi; Akbar Biglarian
Journal:  Neurol Sci       Date:  2018-03-28       Impact factor: 3.307

8.  Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy.

Authors:  G Said; D Baudoin; K Toyooka
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

9.  Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.

Authors:  Marcel Roos; Dimitrios Oikonomou; Maximilian von Eynatten; Peter B Luppa; Uwe Heemann; Jens Lutz; Marcus Baumann; Peter P Nawroth; Angelika Bierhaus; Per M Humpert
Journal:  Cardiovasc Diabetol       Date:  2010-09-07       Impact factor: 9.951

10.  Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors.

Authors:  Jackie Elliott; Solomon Tesfaye; Nish Chaturvedi; Rajiv A Gandhi; Lynda K Stevens; Celia Emery; John H Fuller
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.